BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology report, 2020 - academic.oup.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology report, 2020 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
[PDF][PDF] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
ZN Li, L Zhao, LF Yu, MJ Wei - pdfs.semanticscholar.org
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy.
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - europepmc.org
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
[PDF][PDF] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - academic.oup.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy.
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - go.gale.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy.
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - search.ebscohost.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
[HTML][HTML] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy.
ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology Report, 2020 - europepmc.org
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …